Literature DB >> 34185090

The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications.

Patrick Y Wen1, Roger J Packer2,3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34185090      PMCID: PMC8328017          DOI: 10.1093/neuonc/noab120

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  5 in total

1.  Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.

Authors:  Annekathrin Reinhardt; Damian Stichel; Daniel Schrimpf; Felix Sahm; Andrey Korshunov; David E Reuss; Christian Koelsche; Kristin Huang; Annika K Wefers; Volker Hovestadt; Martin Sill; Dorothee Gramatzki; Joerg Felsberg; Guido Reifenberger; Arend Koch; Ulrich-W Thomale; Albert Becker; Volkmar H Hans; Marco Prinz; Ori Staszewski; Till Acker; Hildegard Dohmen; Christian Hartmann; Wolf Mueller; Muin S A Tuffaha; Werner Paulus; Katharina Heß; Benjamin Brokinkel; Jens Schittenhelm; Camelia-Maria Monoranu; Almuth Friederike Kessler; Mario Loehr; Rolf Buslei; Martina Deckert; Christian Mawrin; Patricia Kohlhof; Ekkehard Hewer; Adriana Olar; Fausto J Rodriguez; Caterina Giannini; Amulya A NageswaraRao; Uri Tabori; Nuno Miguel Nunes; Michael Weller; Ute Pohl; Zane Jaunmuktane; Sebastian Brandner; Andreas Unterberg; Daniel Hänggi; Michael Platten; Stefan M Pfister; Wolfgang Wick; Christel Herold-Mende; David T W Jones; Andreas von Deimling; David Capper
Journal:  Acta Neuropathol       Date:  2018-03-21       Impact factor: 17.088

2.  Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.

Authors:  Kohei Fukuoka; Yasin Mamatjan; Ruth Tatevossian; Michal Zapotocky; Scott Ryall; Ana Guerreiro Stucklin; Julie Bennett; Liana Figueiredo Nobre; Anthony Arnoldo; Betty Luu; Ji Wen; Kaicen Zhu; Alberto Leon; Dax Torti; Trevor J Pugh; Lili-Naz Hazrati; Normand Laperriere; James Drake; James T Rutka; Peter Dirks; Abhaya V Kulkarni; Michael D Taylor; Ute Bartels; Annie Huang; Gelareh Zadeh; Kenneth Aldape; Vijay Ramaswamy; Eric Bouffet; Matija Snuderl; David Ellison; Cynthia Hawkins; Uri Tabori
Journal:  Neuro Oncol       Date:  2020-10-14       Impact factor: 12.300

Review 3.  Pediatric low-grade gliomas: next biologically driven steps.

Authors:  David T W Jones; Mark W Kieran; Eric Bouffet; Sanda Alexandrescu; Pratiti Bandopadhayay; Miriam Bornhorst; David Ellison; Jason Fangusaro; Michael J Fisher; Nicholas Foreman; Maryam Fouladi; Darren Hargrave; Cynthia Hawkins; Nada Jabado; Maura Massimino; Sabine Mueller; Giorgio Perilongo; Antoinette Y N Schouten van Meeteren; Uri Tabori; Katherine Warren; Angela J Waanders; David Walker; William Weiss; Olaf Witt; Karen Wright; Yuan Zhu; Daniel C Bowers; Stefan M Pfister; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

Review 4.  Medulloblastomics revisited: biological and clinical insights from thousands of patients.

Authors:  Volker Hovestadt; Olivier Ayrault; Fredrik J Swartling; Giles W Robinson; Stefan M Pfister; Paul A Northcott
Journal:  Nat Rev Cancer       Date:  2019-12-09       Impact factor: 69.800

5.  Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.

Authors:  Lorena V Baroni; Lakshmikirupa Sundaresan; Ayala Heled; Hallie Coltin; Kristian W Pajtler; Tong Lin; Thomas E Merchant; Roger McLendon; Claudia Faria; Molly Buntine; Christine L White; Stefan M Pfister; Mark R Gilbert; Terri S Armstrong; Eric Bouffet; Sachin Kumar; Michael D Taylor; Kenneth D Aldape; David W Ellison; Nicholas G Gottardo; Marcel Kool; Andrey Korshunov; Jordan R Hansford; Vijay Ramaswamy
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

  5 in total
  29 in total

1.  Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.

Authors:  Débora Cabral de Carvalho Corrêa; Francine Tesser-Gamba; Indhira Dias Oliveira; Nasjla Saba da Silva; Andrea Maria Capellano; Maria Teresa de Seixas Alves; Patrícia Alessandra Dastoli; Sergio Cavalheiro; Silvia Regina Caminada de Toledo
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-09       Impact factor: 4.553

Review 2.  Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours.

Authors:  Roger J Packer; Patrick Y Wen; Craig Horbinski; Tamar Berger
Journal:  Nat Rev Neurol       Date:  2022-06-21       Impact factor: 44.711

3.  Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.

Authors:  Paulina Śledzińska; Marek Bebyn; Ewelina Szczerba; Jacek Furtak; Maciej Harat; Natalia Olszewska; Katarzyna Kamińska; Janusz Kowalewski; Marzena A Lewandowska
Journal:  Mol Diagn Ther       Date:  2022-09-02       Impact factor: 4.476

4.  Pediatric high-grade gliomas and the WHO CNS Tumor Classification-Perspectives of pediatric neuro-oncologists and neuropathologists in light of recent updates.

Authors:  Gerrit H Gielen; Joshua N Baugh; Dannis G van Vuurden; Sophie E M Veldhuijzen van Zanten; Darren Hargrave; Maura Massimino; Veronica Biassoni; Andres Morales la Madrid; Michael Karremann; Maria Wiese; Ulrich Thomale; Geert O Janssens; André O von Bueren; Thomas Perwein; Gunther Nussbaumer; Eelco W Hoving; Pitt Niehusmann; Marco Gessi; Robert Kwiecien; Simon Bailey; Torsten Pietsch; Felipe Andreiuolo; Christof M Kramm
Journal:  Neurooncol Adv       Date:  2022-05-20

Review 5.  Supramarginal Resection for Glioblastoma: It Is Time to Set Boundaries! A Critical Review on a Hot Topic.

Authors:  Francesco Guerrini; Elena Roca; Giannantonio Spena
Journal:  Brain Sci       Date:  2022-05-16

6.  Gliosarcoma: The Distinct Genomic Alterations Identified by Comprehensive Analysis of Copy Number Variations.

Authors:  Chuan-Dong Cheng; Cheng Chen; Li Wang; Yong-Fei Dong; Yang Yang; Yi-Nan Chen; Wan-Xiang Niu; Wen-Chao Wang; Qing-Song Liu; Chao-Shi Niu
Journal:  Anal Cell Pathol (Amst)       Date:  2022-06-15       Impact factor: 4.133

Review 7.  Molecular Aberrations Stratify Grade 2 Astrocytomas Into Several Rare Entities: Prognostic and Therapeutic Implications.

Authors:  Valeria Internò; Giacomo Triggiano; Pierluigi De Santis; Luigia Stefania Stucci; Marco Tucci; Camillo Porta
Journal:  Front Oncol       Date:  2022-06-10       Impact factor: 5.738

8.  The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers.

Authors:  Marija Skoblar Vidmar; Andrej Doma; Uroš Smrdel; Katarina Zevnik; Andrej Studen
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

Review 9.  Molecular and Circulating Biomarkers in Patients with Glioblastoma.

Authors:  Nadia Senhaji; Asmae Squalli Houssaini; Salma Lamrabet; Sara Louati; Sanae Bennis
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

10.  Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making.

Authors:  Mary Jane Lim-Fat; Gilbert C Youssef; Mehdi Touat; J Bryan Iorgulescu; Sydney Whorral; Marie Allen; Rifaquat Rahman; Ugonma Chukwueke; J Ricardo McFaline-Figueroa; Lakshmi Nayak; Eudocia Q Lee; Tracy T Batchelor; Omar Arnaout; Pier Paolo Peruzzi; E Antonio Chiocca; David A Reardon; David Meredith; Sandro Santagata; Rameen Beroukhim; Wenya Linda Bi; Keith L Ligon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2022-07-01       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.